{"ok":true,"data":[{"type":"nse_announcement","source":"regulatory","text":"Sun Pharmaceutical Industries Limited has informed the Exchange about Investor Presentation","date":"2026-09-23"},{"type":"nse_announcement","source":"regulatory","text":"Sun Pharmaceutical Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","date":"2026-09-26"},{"type":"nse_announcement","source":"regulatory","text":"Receipt of approval of the shareholders for reclassification of shareholder category","date":"2026-09-27"},{"type":"bse_announcement","source":"bse_filing","text":"Completion And Result Of Postal Ballot Dated 25 August 2026","date":"2026-09-28"},{"type":"bse_announcement","source":"bse_filing","text":"Announcement under Regulation 30 (LODR)-Press Release / Media Release","date":"2026-09-28"},{"type":"nse_announcement","source":"regulatory","text":"Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release for Lerodalcibep licensing agreement.","date":"2026-09-28"},{"type":"bse_announcement","source":"bse_filing","text":"ESG Overview For FY 2025-26","date":"2026-09-29"},{"type":"nse_announcement","source":"regulatory","text":"Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Completion and Result of Postal Ballot dated 25 August 2026'.","date":"2026-09-29"},{"type":"bse_announcement","source":"bse_filing","text":"Announcement under Regulation 30 (LODR)-Newspaper Publication","date":"2026-09-30"},{"type":"nse_announcement","source":"regulatory","text":"Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'ESG Overview for FY 2025-26'.","date":"2026-09-30"},{"type":"bse_announcement","source":"bse_filing","text":"Shareholder Meeting / Postal Ballot-Notice of Postal Ballot","date":"2026-10-01"},{"type":"bse_announcement","source":"bse_filing","text":"Announcement under Regulation 30 (LODR)-Press Release / Media Release","date":"2026-10-01"},{"type":"nse_announcement","source":"regulatory","text":"Newspaper Publication about the opening of Special Window for transfer of physical shares","date":"2026-10-01"},{"type":"nse_announcement","source":"regulatory","text":"Notice of Postal Ballot October 2026","date":"2026-10-02"},{"type":"nse_announcement","source":"regulatory","text":"Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 01, 2026, titled \"New LEQSELVI® (deuruxolitinib) Two-YearData in Severe Alopecia Areata Showed Sustained Efficacy and Safety at EADV Congress 2026\".","date":"2026-10-02"}]}